Berkeley Heights, New Jersey, United States
Jun 17, 2019
Required Education
Masters Degree/MBA
Position Type
Full time
Req #: 1804481
Location: Berkeley Heights, New Jersey, United States
Job Category: Clinical Operations
Work Location: 300 Connell Dr 07922
Organization: Biostatistics
Employee Status: Full-time
Job Type: Regular

Responsibilities will include, but are not limited to, the following:

Contribute to efficient study design, preparing statistical consideration sections and providing input into other protocol sections. Perform simulations for ED statistical innovative designs. Prepare statistical analysis plans including table shells. Analyze clinical trial data; work with programmers to provide tables, listings and graphs, including ad hoc validation. Maintain / upgrade home-grown ED Stats software with ED Bayesian Methods. Review, synthesize, interpret and report analysis results. Provide ad hoc data driven analyses. Provide statistical input for the preparation of final study reports and other required documents. Escalates issues to functional management as necessary. Makes recommendations or resolves technical, quality, and timeline issues.

Skills/Knowledge Required:
  • MS or Ph.D in Statistics.
  • At least 2 years clinical drug development experience with a Master's degree; or no additional experience with a Ph.D. as a study statistician.
  • 1 plus years statistical computing experience (e.g. SAS, R, or other statistical computing software)
  • Knowledge of MS Office products (Word, Excel, PowerPoint)
  • Demonstrated skill in statistical methodologies and data analysis, especially in Bayesian methods.
  • Knowledge of clinical trial design concepts. Also knowledge of Bayesian innovative designs in ED
  • Demonstrated ability to learn statistical regulatory requirements.
  • Good interpersonal, communication, writing and organizational skills.
  • Ability to work in a team environment with medical personnel, clinical monitors, data managers, programmers and medical writers.

About Us


At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.